"The FDA anticipates that there will be an adequate and diverse supply of approved trivalent seasonal ... saying he believed VRBPAC was merely 'rubber stamping' the decisions made by the WHO's ...

The so-called "mainstream" media — a festering menagerie of corporate whores, ideological janissaries, and risk-averse ...

The implant is designed to address cartilage defects in the knee that cause persistent pain, according to a press release from the company.

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

The Department of Health and Human Services is calling on companies to phase out all petroleum-based dyes by the end of next ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) to treat adults and ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade ...

Perspective from Thomas B. Casale, MD The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain symptomatic despite histamine-1 ...

The Food and Drug Administration (FDA) has approved a tablet formulation of Livmarli ® (maralixibat).